PHOSPHATE
|
|
Salt |
Form |
Strength |
Elemental P04- |
Other |
|
Phosphates solution |
liquid |
500mg/4mL |
500mg |
4mL is equivalent to
1x500mg tab Phosphate Sandoz® |
|
Potassium phosphate |
injection |
|
3 mMol/mL |
4.4 mMol/mL potassium |
|
Sodium phosphate |
injection |
|
3 mMol/mL |
4.0 mMol/mL sodium |
Treatment of Hypophosphatemia:
|
|
|
|
|
Recent and uncomplicated hypophosphatemia |
PO |
Phosphates solution 500mg (16mMol, 4mL) 2-4 times daily |
|
IV |
15 mMol PO43- IV x 1 |
|
|
Symptomatic hypophosphatemia |
IV |
15-30 mMol PO43- IV given in 1-2 doses Higher
doses up to 0.5 mMol PO43-/kg have been used for
serum (sodium phosphate formulation preferred with higher doses due to no potassium content).
Additional doses should be guided by serum phosphate levels taken 6-24
hours after the infusion. Also, check serum potassium and calcium
levels. |
Administration
|
|
|
|
Potassium phosphate |
Maximum
peripheral concentration is 15 mMol PO43- (5mL) in
250 mL NS or D5W (higher concentrations must be run centrally). Infuse
over |
|
Sodium phosphate |
Dilute
dose in minimum 100mL NS or D5W. Infuse up to 15 mMol PO43-
over 2 hrs; infuse > 15 mMol PO43- over 4-6 hrs. |
|
|